K W Muir Selected Research

K W Muir Research Topics

16	Stroke (Strokes) 01/2021 - 01/2000
8	Ischemic Stroke 01/2021 - 10/2000
3	Infarction (Infarctions) 03/2006 - 01/2001
2	Thrombosis (Thrombus) 12/2020 - 01/2010
2	Atrial Fibrillation 09/2020 - 01/2000
1	Disease Progression 01/2021
1	CADASIL 01/2021
1	Hemorrhage 01/2016
1	Embolic Stroke 02/2011
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 03/2006
1	Lacunar Stroke 02/2004
1	Hemorrhagic Stroke 09/2001
1	Pre-Eclampsia (Preeclampsia) 01/2001
1	Myocardial Infarction 01/2001
1	Ischemia 11/2000
1	Vomiting 11/2000
1	Hyponatremia 11/2000
1	Nausea 11/2000
1	Hallucinations (Hallucination) 11/2000
1	Confusion (Bewilderment) 11/2000
1	Injection Site Reaction 11/2000
1	Back Pain (Backache) 10/2000
1	Headache (Headaches) 10/2000
1	Cerebral Hemorrhage 10/2000
1	Craniocerebral Trauma (Head Injury) 10/2000
1	Brain Injuries (Brain Injury) 10/2000
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2000

6	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2000
3	MagnesiumIBA 02/2004 - 01/2001
3	Apolipoproteins E (ApoE)IBA 02/2003 - 10/2000
2	Neuroprotective AgentsIBA 01/2003 - 11/2002
2	ApolipoproteinsIBA 09/2001 - 10/2000
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	LipidsIBA 01/2016
1	Contrast MediaIBA 01/2010
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2010
1	Therapeutic UsesIBA 11/2008
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 11/2008
1	thiamine triphosphorate (TTP)IBA 03/2006
1	Excitatory Amino Acid AntagonistsIBA 01/2003
1	Pharmaceutical PreparationsIBA 01/2003
1	sipatrigineIBA 11/2000
1	Glutamic Acid (Glutamate)FDA Link 11/2000
1	Sodium Channel BlockersIBA 11/2000
1	AnticoagulantsIBA 01/2000

6	Thrombolytic Therapy 02/2011 - 01/2000
2	Contraindications 02/2003 - 01/2000
1	Polypharmacy 01/2021
1	Thrombectomy 09/2020
1	Operative Surgical Procedures 02/2011
1	Carotid Endarterectomy 02/2011
1	Therapeutics 02/2003
1	Intravenous Infusions 11/2000
1	Punctures 10/2000
1	Compression Stockings 06/2000